For many young ophthalmologists, the backbone of daily clinical practice is formed by cataract surgery. Surgeons strive to improve patient outcomes, enhance the patient experience and make their ...
Cataract surgery in the highly myopic patient, typically defined by an axial length greater than 26 mm, represents one of the most demanding scenarios in refractive cataract surgery.While these ...
Add Yahoo as a preferred source to see more of our stories on Google. Cataract surgery removes the clouded lens of the eye and replaces it with a new, clear lens. Ivan-balvan/iStock via Getty Images ...
In response to this education gap, Eye Surgery Today was founded by nationally recognized key opinion leaders (KOLs) to make high-quality eye surgery education accessible to everyone.
The planned Phase 3 study is a randomized, placebo-controlled, double-masked, multicenter clinical trial designed to evaluate the safety and efficacy of TRIESENCE in patients undergoing cataract ...
FDA IND clearance enables a phase 3 program evaluating TRIESENCE for postoperative ocular inflammation and pain following cataract surgery, aiming to broaden on-label use beyond current intraocular ...
Unlike traditional EDOF lenses, Lucidis® delivers full-range visual performance comparable to a premium trifocal IOL without disturbances.
New research in squirrels has spotted a protein in the eye that reverses the vision-robbing condition Surgeries come with risks, so any non-surgical option for cataracts is welcome MONDAY, Sept. 23, ...
Raleigh, NC - March 02, 2026 - PRESSADVANTAGE - Porter Ophthalmology announced today that Dr. Bhumi Kinariwala will ...
Madison Artale’s world was darkening before it even began. Diagnosed with congenital cataracts at less than two months old, the baby — born in Bellevue, Nebraska, on Oct. 1 — was in danger of losing ...
CHEYENNE — Local patients seeking laser-assisted cataract surgery will no longer have to commute down south to Colorado after the first laser-assisted cataract surgeries began in Cheyenne last week at ...